Licensing, Mergers & Acquisitions

Case Study

Amunix Pharmaceuticals

  • Geller Biopharm, Inc (GBP) was retained to work with Amunix Pharmaceuticals as its exclusive licensing advisor
  • Initial work entailed helping to position the company for licensing: assisting in building appropriate materials including, PowerPoint presentation and online data room.
  • Sent out emails and made phone calls to over 200 potential partners from our personalized database, including over 5000 potential targets.
  • These led to over 100 meetings by phone and in person with promising potential partners from the US, Europe, Asia, LATAM, MENA, and other regions.
  • Attended, with Management, partnering and medical conferences including, BioEurope, BIO International and ASCO.
  • Successfully negotiated term sheet and licensing agreement with Celgene
  • Successfully negotiated term sheet and licensing agreement with Merck
  • Successfully negotiated several additional confidential agreements
  • This case demonstrates our ability to successfully complete licensing agreements for a company with strong science and management
  • Past performance is not a guarantee of future results
Geller Biopharm

  Broker / Dealer services provided by Pickwick Capital Partners, LLC. Member FINRA / SIPC

Download our presentation

Get a digital copy of our PDF presentation

Download PDF